Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis

Meta Analysis ◽

Inadequate Response ◽

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.12822 ◽

2015 ◽

Vol 19 (11) ◽

pp. 1103-1111 ◽

Cited By ~ 15

Author(s):

Young Ho Lee ◽

Sang-Cheol Bae

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

Arthritis & Rheumatology ◽

10.1002/art.39944 ◽

2017 ◽

Vol 69 (2) ◽

pp. 277-290 ◽

Cited By ~ 71

Author(s):

Roy Fleischmann ◽

Janet van Adelsberg ◽

Yong Lin ◽

Geraldo da Rocha Castelar-Pinheiro ◽

Jan Brzezicki ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Inadequate Response ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis

Rheumatology International ◽

10.1007/s00296-017-3675-8 ◽

2017 ◽

Vol 37 (7) ◽

pp. 1053-1064 ◽

Cited By ~ 5

Author(s):

Abdelrahman Ibrahim Abushouk ◽

Hussien Ahmed ◽

Ammar Ismail ◽

Ahmed Elmaraezy ◽

Ahmed Said Badr ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Inadequate Response ◽

Safety And Efficacy ◽

Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2019.25.11.1268 ◽

2019 ◽

Vol 25 (11) ◽

pp. 1268-1280

Author(s):

Noemi Muszbek ◽

Clare Proudfoot ◽

Marie Fournier ◽

Chieh-I Chen ◽

Andreas Kuznik ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Adult Patients ◽

Inadequate Response ◽

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

Arthritis & Rheumatology ◽

10.1002/art.38617 ◽

2014 ◽

Vol 66 (7) ◽

pp. 1693-1704 ◽

Cited By ~ 137

Author(s):

Mark C. Genovese ◽

Maria Greenwald ◽

Chul-Soo Cho ◽

Alberto Berman ◽

Ling Jin ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Randomized Study ◽

Biologic Agents ◽

Interleukin 17 ◽

Inadequate Response ◽

Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis

Advances in Therapy ◽

10.1007/s12325-018-0869-8 ◽

2019 ◽

Vol 36 (3) ◽

pp. 721-745

Author(s):

László Gulácsi ◽

Zsombor Zrubka ◽

Valentin Brodszky ◽

Fanni Rencz ◽

Rieke Alten ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Literature Review ◽

Systematic Literature Review ◽

Tumor Necrosis ◽

Meta Analysis ◽

Term Efficacy ◽

A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA

PharmacoEconomics ◽

10.1007/s40273-019-00829-x ◽

2019 ◽

Vol 38 (1) ◽

pp. 39-56 ◽

Cited By ~ 3

Author(s):

Elizabeth Wehler ◽

Natalie Boytsov ◽

Claudia Nicolay ◽

Oscar Herrera-Restrepo ◽

Stacey Kowal

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Budget Impact ◽

Inadequate Response ◽

Severe Rheumatoid Arthritis ◽

Responder Analysis ◽

The Usa ◽

AB0552 Relative efficacy and tolerability of intravenous and subcutaneous abatacept compared with tumor necrosis factor inhibitors in rheumatoid arthritis patients with an inadequate response to conventional disease-modifying antirheumatic drugs

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.552 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 670.1-670

Author(s):

M. Hochberg ◽

S. Berry ◽

K. Broglio ◽

A. Nadkarni ◽

L. Rosenblatt ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Inadequate Response ◽

Relative Efficacy ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

FRI0256 Risk of Relapse after Discontinuing Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients with Low Disease Activity: A Systematic Review and Meta-Analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.5498 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 476.1-476

Author(s):

N. Filippi ◽

J. Morel ◽

B. Combe ◽

C. Lukas

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Tumor Necrosis Factor ◽

Disease Activity ◽

Tumor Necrosis ◽

Meta Analysis ◽

Low Disease Activity ◽

Necrosis Factor ◽

Risk Of Relapse

Correction to: A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA

PharmacoEconomics ◽

10.1007/s40273-019-00857-7 ◽

2019 ◽

Vol 38 (1) ◽

pp. 123-123

Author(s):

Elizabeth Wehler ◽

Natalie Boytsov ◽

Claudia Nicolay ◽

Oscar Herrera-Restrepo ◽

Stacey Kowal

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Budget Impact ◽

Inadequate Response ◽

Severe Rheumatoid Arthritis ◽

Responder Analysis ◽

The Usa ◽